Oxford Textbook of Heart Failure
Theresa A. McDonagh, Roy S. Gardner, Andrew L. Clark, Henry Dargie
Oxford University Press, 14 lug 2011 - 641 pagine
Although the incidence of coronary heart disease is falling, its major complication, heart failure, is increasing in frequency. All health care practitioners will encounter patients with heart failure, presenting either acutely or in need of chronic heart failure management. However with recent advances in medical therapy, the prognosis of the condition has improved dramatically so that whereas once heart failure was a pre-terminal diagnosis, now for many it is treatable. Taking the reader from an understanding of the basic mechanisms of heart failure through to an appreciation of the complexities of heart failure management and the remarkable improvements possible with good treatment, this definitive textbook is written by internationally renowned leaders in their field and comprehensively covers all aspects necessary to manage a patient with heart failure. In full colour throughout, containing over 300 illustrations, and supported by detailed referencing from the huge evidence base that has developed over the last two decades, Oxford Textbook of Heart Failure also includes extensive chapters on common co-morbidities, and will be essential reading for consultant cardiologists and those in training, general physicians and those caring of the elderly, cardiothoracic surgeons, primary care doctors, pharmacists, and specialist nurses. The printed edition is complemented by 6 months free access to an online version (also available for separate purchase on subscription basis), allowing users to search the text, and download the figures for use in PowerPoint presentations.
Cosa dicono le persone - Scrivi una recensione
Nessuna recensione trovata nei soliti posti.
What is heart failure?
The aetiology of heart failure
Pathophysiology of heart failure cellular and molecular changes
Pathophysiology of heart failure
The diagnosis of heart failure
Medical therapy for chronic heart failure
Medical therapy for acute heart failure
Device therapy for heart failure
Surgical therapy for heart failure
Ventilatory strategies in heart failure
abnormalities ACE inhibitors activation acute aetiology aldosterone angiotensin aortic arrhythmias assessment associated atrial fibrillation Ca2+ cardiac resynchronization therapy Cardiology cardiomyocyte Cardiovasc cardiovascular cause cell chronic heart failure chronic HF Circulation Clin clinical congestive heart failure coronary artery cytokine death defibrillator diabetes diagnosis diastolic digoxin dilated cardiomyopathy diuretic dose drugs echocardiography effects ejection fraction enzyme exercise capacity haemodynamic heart disease HF patients hospitalization hypertension hypertrophy imaging implantation improved increased ischaemic JAm Coll Cardiol Lancet left ventricular dysfunction left ventricular systolic LVEF LVSD metabolic mitral mortality muscle myocardial infarction myocardium myocytes natriuretic peptide normal NYHA class oedema outcome patients with chronic patients with heart patients with HF perfusion placebo plasma prognostic protein pulmonary randomized receptor reduced regurgitation remodelling renal right ventricular risk spironolactone survival symptomatic symptoms syndrome systolic systolic dysfunction tachycardia tion tolvaptan treatment trial valve vascular venous ventricular function